Next Generation Sequencing Market by End-user, Product and Geography - Forecast and Analysis 2023-2027

Published: Oct 2023 Pages: 171 SKU: IRTNTR71618

Next Generation Sequencing Market Analysis Report 2023-2027:

The Next Generation Sequencing (NGS) market size is estimated to grow at a CAGR of 12.45% between 2022 and 2027. The market size is forecast to increase by USD 3,409.76 million. The growth of the market depends on several factors, including the increased utilization of NGS methods, the growing demand for early diagnosis of genetic disorders, and the availability of a wide range of NGS products.

This report extensively covers next generation sequencing market segments by end-user (academic research, clinical research, pharma and biotech companies, and others), product (consumables and equipment), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the Size of the Next Generation Sequencing Market During the Forecast Period?

To learn more about this report, View Report Sample

Next Generation Sequencing Market: Key Drivers, Trends, Challenges, and Customer Landscape

The increased utilization of NGS methods is notably driving the market growth, although factors such as the lack of clinical validation on direct-to-consumer genetic tests may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Next Generation Sequencing Market Driver

One of the key factors driving the growth of the next generation sequencing market is the increased utilization of next-generation sequencing methods. Rapid developments in next-generation sequencing techniques and the creation of a human genome database have allowed vendors to offer rapid diagnostic services and the capability to diagnose mutations and disorders in human gene sequences. The next generation sequencing techniques provide high processing speed and throughput that can generate a vast number of sequences with many applications in research, as well as in the diagnostic field. This has allowed the vendors to offer reliable genetic testing services and products using next generation sequencing in the market, which will propel the market growth.

Moreover, the next generation sequencing techniques have gained huge popularity for their use in whole viral genome sequencing. Researchers are thoroughly studying and developing further prospectus, which is expected to improve the performance of these techniques as a reliable solution and augment the growth of the market during the forecast period.

Significant Next Generation Sequencing Market Trends

Reduced costs of gene sequencing are the primary trend shaping the market growth. Advances in gene sequencing techniques have enabled the reduction in turnaround time and cost of testing procedures. Advances in high-throughput genetic testing procedures, biochips, and NGS techniques have reduced the cost significantly. This has impacted the market by allowing vendors to offer low-cost services and overcome cost-related challenges.

This has led to a considerable increase in the consumer base for vendors (such as Illumina, QIAGEN, Thermo Fisher Scientific, Bio-Rad Laboratories, Danaher, and PerkinElmer) by providing access to more people with limited budgets and overcoming the challenge of unaffordable prices. With the adoption of NGS and fluorescence-based fully automated sequencing technologies, a sharp decline in the cost of sequencing and considerable improvements in accuracy have been witnessed. This will boost the growth of the market during forecast period.

Major Next Generation Sequencing Market Challenge

The lack of clinical validation on direct-to-consumer genetic tests will be a major challenge for the next generation sequencing market during the forecast period. The clinical validity of direct-to-consumer genetic tests has been consistently questioned due to the presence of limited scientific evidence. This negatively impacts the commercialization of pre-disposition tests. Direct-to-consumer tests incorporate single-gene testing by Sanger sequencing as it is the most cost-effective method for the study of inherited disorders with low phenotypic and genetic heterogeneity. With the rise in the levels of heterogeneity, it is more efficient to use next generation sequencing panels to study multiple targets simultaneously.

Moreover, direct-to-consumer genetic tests have limited accuracy and can often generate false-positive or false-negative results, which can have a negative impact on the health of consumers and lead to emotional and mental distress. This has compelled regulatory authorities to bring vendors under scrutiny and made the disclosure of risk information (including the authorized tests) and instructions mandatory. Such factors will hinder the market growth during the forecast period.

Key Next Generation Sequencing Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Next Generation Sequencing Market Customer Landscape

Who are the Major Next Generation Sequencing Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

10X Genomics Inc.: The company offers next generation sequencing such as chromium single cell, visium spatial, and xenium in situ. Also, the company focuses on manufacturing gene sequencing technology used in scientific research.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • 10X Genomics Inc.
  • Azenta Inc.
  • BGI Genomics Co. Ltd.
  • Bio Rad Laboratories Inc.
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • Illumina Inc.
  • Konica Minolta Inc.
  • Laboratory Corp. of America Holdings
  • Merck KGaA
  • Nabsys Inc.
  • OPKO Health Inc.
  • Oxford Nanopore Technologies plc
  • Perkin Elmer Inc.
  • PierianDx Inc.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Next Generation Sequencing Market?

The next generation sequencing market share growth by the academic research segment will be significant during the forecast period. The next generation sequencing market can be segmented by end users into several categories, one of which is academic research. Academic research institutions, including universities and research institutions, are major users of NGS technologies for various applications.

Get a glance at the market contribution of various segments View the PDF Sample

The academic research segment was valued at USD 1,423.35 million in 2017 and continued to grow until 2021. Academic researchers use NGS technology for a variety of purposes, including basic research, drug discovery, personalized medicine, and clinical diagnostics. This technology enables rapid sequencing of large amounts of genetic data, allowing researchers to analyze genetic variation and better understand disease mechanisms. Some of the key factors driving the adoption of NGS technology in academic research are the declining cost of sequencing, the availability of easy-to-use software and analytical tools, and the growing demand for personalized and precision medicine.

As a result, many NGS companies are focused on developing products and services that meet the needs of academic researchers. These include affordable sequencing instruments, easy-to-use software, and data analysis platforms that can be customized to your specific research needs. Overall, the academic research segment is an important and growing market for NGS technology and is expected to remain the leading end-user segment in the global next-generation sequencing market during the forecast period.  

Which are the Key Regions for the Next Generation Sequencing Market?

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In 2022, North America was the major geographic segment of the global next-generation sequencing market. It had the largest sales share, and the United States was the leading country in the market. The advent of NGS has lowered the cost of genome sequencing. However, there is a growing demand for early detection of diseases such as cancer in this region. Furthermore, the presence of conglomerate companies such as Illumina, Thermo Fisher Scientific, and PerkinElmer, along with the growing focus on genome mapping programs, are also contributing significantly to the growth of the next generation sequencing market in North America.

In 2020, COVID-19 drove the growth of the regional next generation sequencing market owing to the increasing need for genomic testing and research activities to treat patients with COVID-19 in countries including the US, Canada, and Mexico. The genome sequences of the SARS-CoV-2 virus, which were deposited in public databases, were pivotal resources in understanding its virulence and providing approaches to the discovery of effective therapeutics and vaccines. Core NGS features in regional populations were used for comparative analysis to identify unique features of SARS-CoV-2 and assist in epidemiologic and public health endeavors. Such factors increased the demand for NGS products and services in the region in 2022. All these factors are expected to drive the market during the forecast period.

Segment Overview

The next generation sequencing market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • End-User Outlook (USD Million, 2017 - 2027)
    • Academic research
    • Clinical research
    • Pharmaceutical and biotechnology companies
    • Others
  • Product Outlook (USD Million, 2017 - 2027)
    • Consumables
    • Equipment
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Australia
      • Argentina
      • Rest of the world

Parent Market Analysis

Technavio categorizes the global next generation sequencing market as a part of the global life sciences tools and services market. The parent, global life sciences tools and services market covers products and companies engaged in research and development (R&D) of a variety of product categories, including capital equipment, instruments, accessories, and consumables that are used for R&D on pharmaceuticals and biotechnology products and laboratory diagnosis of various diseases. It also covers life sciences-related services, including contract research, contract manufacturing, and contract sales. Our market research report has extensively covered external factors influencing the parent market growth during the forecast period.

Next Generation Sequencing Market Scope

Report Coverage

Details

Page number

171

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 12.45%

Market growth 2023-2027

USD 3,409.76 million

Market structure

Fragmented

YoY growth 2022-2023(%)

11.55

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

10X Genomics Inc., Azenta Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Konica Minolta Inc., Laboratory Corp. of America Holdings, Merck KGaA, Nabsys Inc., OPKO Health Inc., Oxford Nanopore Technologies plc, Perkin Elmer Inc., PierianDx Inc., Psomagen Inc., QIAGEN NV, Standard BioTools Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Next Generation Sequencing Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the market size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behaviour
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of market vendors

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global next generation sequencing market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global next generation sequencing market 2017 - 2021 ($ million)
    • 4.2 End-user Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.3 Product Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Academic research - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Academic research - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Academic research - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Academic research - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Academic research - Year-over-year growth 2022-2027 (%)
    • 6.4 Clinical research - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
    • 6.5 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
    • 6.6 Others - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.7 Market opportunity by End-user
      • Exhibit 50: Market opportunity by End-user ($ million)
      • Exhibit 51: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 52: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 53: Data Table on Product - Market share 2022-2027 (%)
    • 7.2 Comparison by Product
      • Exhibit 54: Chart on Comparison by Product
      • Exhibit 55: Data Table on Comparison by Product
    • 7.3 Consumables - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Consumables - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
    • 7.4 Equipment - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Equipment - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Equipment - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Equipment - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Equipment - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Product
      • Exhibit 64: Market opportunity by Product ($ million)
      • Exhibit 65: Data Table on Market opportunity by Product ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 Canada - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.10 China - Market size and forecast 2022-2027
      • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.11 UK - Market size and forecast 2022-2027
      • Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ million)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 10X Genomics Inc.
              • Exhibit 115: 10X Genomics Inc. - Overview
              • Exhibit 116: 10X Genomics Inc. - Product / Service
              • Exhibit 117: 10X Genomics Inc. - Key offerings
            • 12.4 Azenta Inc.
              • Exhibit 118: Azenta Inc. - Overview
              • Exhibit 119: Azenta Inc. - Business segments
              • Exhibit 120: Azenta Inc. - Key offerings
              • Exhibit 121: Azenta Inc. - Segment focus
            • 12.5 BGI Genomics Co. Ltd.
              • Exhibit 122: BGI Genomics Co. Ltd. - Overview
              • Exhibit 123: BGI Genomics Co. Ltd. - Product / Service
              • Exhibit 124: BGI Genomics Co. Ltd. - Key offerings
            • 12.6 Bio Rad Laboratories Inc.
              • Exhibit 125: Bio Rad Laboratories Inc. - Overview
              • Exhibit 126: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 127: Bio Rad Laboratories Inc. - Key news
              • Exhibit 128: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 129: Bio Rad Laboratories Inc. - Segment focus
            • 12.7 Eurofins Scientific SE
              • Exhibit 130: Eurofins Scientific SE - Overview
              • Exhibit 131: Eurofins Scientific SE - Business segments
              • Exhibit 132: Eurofins Scientific SE - Key news
              • Exhibit 133: Eurofins Scientific SE - Key offerings
              • Exhibit 134: Eurofins Scientific SE - Segment focus
            • 12.8 F. Hoffmann La Roche Ltd.
              • Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.9 Illumina Inc.
              • Exhibit 140: Illumina Inc. - Overview
              • Exhibit 141: Illumina Inc. - Business segments
              • Exhibit 142: Illumina Inc. - Key news
              • Exhibit 143: Illumina Inc. - Key offerings
              • Exhibit 144: Illumina Inc. - Segment focus
            • 12.10 Konica Minolta Inc.
              • Exhibit 145: Konica Minolta Inc. - Overview
              • Exhibit 146: Konica Minolta Inc. - Business segments
              • Exhibit 147: Konica Minolta Inc. - Key news
              • Exhibit 148: Konica Minolta Inc. - Key offerings
              • Exhibit 149: Konica Minolta Inc. - Segment focus
            • 12.11 Laboratory Corp. of America Holdings
              • Exhibit 150: Laboratory Corp. of America Holdings - Overview
              • Exhibit 151: Laboratory Corp. of America Holdings - Business segments
              • Exhibit 152: Laboratory Corp. of America Holdings - Key news
              • Exhibit 153: Laboratory Corp. of America Holdings - Key offerings
              • Exhibit 154: Laboratory Corp. of America Holdings - Segment focus
            • 12.12 Merck KGaA
              • Exhibit 155: Merck KGaA - Overview
              • Exhibit 156: Merck KGaA - Business segments
              • Exhibit 157: Merck KGaA - Key news
              • Exhibit 158: Merck KGaA - Key offerings
              • Exhibit 159: Merck KGaA - Segment focus
            • 12.13 Perkin Elmer Inc.
              • Exhibit 160: Perkin Elmer Inc. - Overview
              • Exhibit 161: Perkin Elmer Inc. - Business segments
              • Exhibit 162: Perkin Elmer Inc. - Key news
              • Exhibit 163: Perkin Elmer Inc. - Key offerings
              • Exhibit 164: Perkin Elmer Inc. - Segment focus
            • 12.14 QIAGEN NV
              • Exhibit 165: QIAGEN NV - Overview
              • Exhibit 166: QIAGEN NV - Product / Service
              • Exhibit 167: QIAGEN NV - Key news
              • Exhibit 168: QIAGEN NV - Key offerings
            • 12.15 Standard BioTools Inc.
              • Exhibit 169: Standard BioTools Inc. - Overview
              • Exhibit 170: Standard BioTools Inc. - Product / Service
              • Exhibit 171: Standard BioTools Inc. - Key news
              • Exhibit 172: Standard BioTools Inc. - Key offerings
            • 12.16 Takara Bio Inc.
              • Exhibit 173: Takara Bio Inc. - Overview
              • Exhibit 174: Takara Bio Inc. - Business segments
              • Exhibit 175: Takara Bio Inc. - Key offerings
              • Exhibit 176: Takara Bio Inc. - Segment focus
            • 12.17 Thermo Fisher Scientific Inc.
              • Exhibit 177: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 178: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 179: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 180: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 181: Thermo Fisher Scientific Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 182: Inclusions checklist
                • Exhibit 183: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 184: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 185: Research methodology
                • Exhibit 186: Validation techniques employed for market sizing
                • Exhibit 187: Information sources
              • 13.5 List of abbreviations
                • Exhibit 188: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              next generation sequencing market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis